Related Experiment Video
Updated: Jan 26, 2026

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
Published on: February 23, 2024
Hydrazones as novel epigenetic modulators: Correlation between TET 1 protein inhibition activity and their iron(II)
Milan Jakubek1, Zdeněk Kejík2, Robert Kaplánek3
1BIOCEV, First Faculty of Medicine, Charles University, Průmyslová 595, 252 50 Vestec, Czech Republic; Department of Analytical Chemistry, Faculty of Chemical Engineering, University of Chemistry and Technology, Technická 5, 166 28 Prague 6, Czech Republic; Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Ke Karlovu 2, 121 08 Prague 2, Czech Republic.
Abstract:
Ten-eleven translocation protein (TET) 1 plays a key role in control of DNA demethylation and thereby of gene expression. Dysregulation of these processes leads to serious pathological states such as oncological and neurodegenerative ones and thus TET 1 targeting is highly requested. Therefore, in this work, we examined the ability of hydrazones (acyl-, aroyl- and heterocyclic hydrazones) to inhibit the TET 1 protein and its mechanism of action. Inhibitory activity of hydrazones 1-7 towards TET 1 was measured. The results showed a high affinity of the tested chelators for iron(II). The study clearly showed a significant correlation between the chelator's affinity for iron(II) ions (represented by the binding constant) and TET 1 protein inhibitory activity (represented by IC50 values).
Insights
Researchers investigated hydrazones as inhibitors of Ten-eleven translocation protein 1 (TET 1), crucial for gene expression. They found a strong link between hydrazone affinity for iron(II) and TET 1 inhibition, suggesting a mechanism for targeting TET 1 in diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Medicinal Chemistry
Background:
- Ten-eleven translocation protein 1 (TET 1) regulates DNA demethylation and gene expression.
- Dysregulation of TET 1 is implicated in oncological and neurodegenerative diseases.
- Targeting TET 1 presents a therapeutic opportunity.
Purpose of the Study:
- To evaluate the inhibitory potential of hydrazones against TET 1.
- To elucidate the mechanism of action for hydrazone-mediated TET 1 inhibition.
Main Methods:
- Synthesis and characterization of acyl-, aroyl-, and heterocyclic hydrazones.
- Assay of inhibitory activity of hydrazones (compounds 1-7) against TET 1.
- Measurement of iron(II) binding affinity (binding constant) for the tested hydrazones.
Main Results:
- Hydrazones demonstrated significant inhibitory activity against TET 1.
- The tested hydrazones exhibited high affinity for iron(II) ions.
- A strong correlation was observed between iron(II) binding affinity and TET 1 inhibitory potency (IC50 values).
Conclusions:
- Hydrazones are effective inhibitors of TET 1.
- The mechanism of TET 1 inhibition by these hydrazones likely involves iron(II) chelation.
- This study provides a basis for developing novel TET 1-targeting therapeutics.
Related Concept Videos
Epigenetic Regulation
Inhibition of Cdk Activity
Feedback Inhibition
Correlations
Ligand Binding and Linkage
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...

